Evidence map›Paper›PMID 42775261›Full record

ReviewRSC advances2026

1,2,3-Triazole-linked DNA biosensors: molecular design to real-time applications.

Gaurav Bhatoe, Nancy George, Gurjaspreet Singh, Anshu, Jandeep Singh

Abstract readReview
In one paragraph

Review in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gaurav BhatoeSchool of Chemical Engineering and Physical Sciences, Lovely Professional University Phagwara-144411 Punjab India singhjandeep@gmail.com.
Nancy GeorgeSchool of Chemical Engineering and Physical Sciences, Lovely Professional University Phagwara-144411 Punjab India singhjandeep@gmail.com.
Gurjaspreet SinghDepartment of Chemistry and Centre of Advanced Studies in Chemistry, Panjab University Chandigarh-160014 India.
AnshuDepartment of Chemistry and Centre of Advanced Studies in Chemistry, Panjab University Chandigarh-160014 India.
Jandeep SinghSchool of Chemical Engineering and Physical Sciences, Lovely Professional University Phagwara-144411 Punjab India singhjandeep@gmail.com.ORCID https://orcid.org/0000-0003-2681-7820

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many aspects of modern life rely on rapid, accurate, and selective detection methodologies, especially for heavy toxins, pathogens, biomolecules, metal ions, and miRNAs. Thus, there is a need for reliable and versatile advanced biosensing platforms that can meet these challenges. CuAAC-assisted systems have emerged as efficient tools for constructing DNA biosensors due to their high efficiency, bioorthogonality, and site-specific conjugation capabilities. This review highlights the role of copper(i)-catalyzed azide-alkyne cycloaddition (CuAAC) in DNA biosensing platforms. Emphasis is placed on the use of CuAAC-aided 1,2,3-triazoles for different linkages, surface modifications and dual-strand linkages. Furthermore, the integration of click chemistry with nanomaterials, DNA-based structures, DNAzymes, CRISPR, and ATRP for signal amplification and highly sensitive detection is discussed. Various signal transduction mechanisms are included, such as fluorescence, electroluminescence, and electrochemical signal outputs. In addition, the review evaluates recent discoveries, underlying mechanisms and current limitations, enabling a more in-depth understanding of how click chemistry is reforming DNA-based biosensing. Overall, this work underscores the power of 1,2,3-triazole to enhance next-generation biosensors with improved sensitivity, selectivity, and real-world applicability.

Identifiers

PMID42775261
PMCPMC13596071

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.